Mirum Pharmaceuticals, Inc. Common Stock MIRM
$100.36
+1.61%
at last close
Analyst Consensus
- Consensus Rating
- Buy (13 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $135.54
- Implied Upside
- +35.0%
- Price Target Range
- $118.00 – $150.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-06 | TD CowenJoseph Thome |
Maintains | Buy | $145 → $140 |
| 2026-08-06 | RBC CapitalLisa Walter |
Maintains | Outperform | $148 → $135 |
| 2026-08-06 | CitizensJonathan Wolleben |
Maintains | Market outperform | $146 → $137 |
| 2026-08-06 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $185 → $140 |
| 2026-07-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $142 → $148 |
| 2026-07-02 | JP MorganJessica Fye |
Maintains | Overweight | $115 → $125 |
| 2026-06-15 | CitizensJonathan Wolleben |
Maintains | Market outperform | $140 → $146 |
| 2026-06-11 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $140 → $150 |
| 2026-06-02 | CitigroupYigal Nochomovitz |
Initiates coverage on | Buy | $145 |
| 2026-05-19 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Outperform | $145 |
| 2026-05-07 | TD CowenJoseph Thome |
Maintains | Buy | $125 → $145 |
| 2026-05-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $128 → $142 |
| 2026-05-07 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $135 → $138 |
| 2026-05-07 | BairdBrian Skorney |
Maintains | Outperform | $112 → $129 |
| 2026-05-05 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $130 → $140 |
| 2026-05-04 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $150 → $175 |
| 2026-04-29 | StifelJames Condulis |
Maintains | Buy | $125 → $130 |
| 2026-04-28 | BairdBrian Skorney |
Maintains | Outperform | $95 → $112 |
| 2026-04-27 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $130 → $150 |
| 2026-04-21 | CitizensJonathan Wolleben |
Reiterates | Market outperform | $132 |
| 2026-03-27 | TD CowenJoseph Thome |
Maintains | Buy | $117 → $125 |
| 2026-03-23 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $130 |
| 2026-03-04 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $101 → $126 |
| 2026-02-26 | Leerink PartnersMani Foroohar |
Maintains | Outperform | $120 → $118 |
| 2026-02-26 | TD CowenJoseph Thome |
Maintains | Buy | $115 → $117 |
| 2026-02-26 | RBC CapitalJoe Kim |
Maintains | Outperform | $130 → $128 |
| 2026-02-26 | CitizensJonathan Wolleben |
Maintains | Market outperform | $140 → $132 |
| 2026-02-26 | StifelDae Gon Ha |
Maintains | Buy | $98 → $125 |
| 2026-02-18 | RBC CapitalJoe Kim |
Initiates coverage on | Outperform | $130 |
| 2026-01-30 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $95 → $123 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $100.36
- Market Cap
- $6.04 billion
- 52-Week Range
- $50.25 – $130.00
- Average Volume
- 706K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.